teclistamab,daratumumab,talquetamab
genmab,janssen
['mmsm', ' emd ']
aa4: -tt showed impressive results in emd - infection rate is a main challenge! (in rw it will be higher)
- tt lack the actual efficacy post bcma exposure (small number) &amp; to answer how to sequence treatment post triple rrm
#mmsm #myeloma #medtiwtter #usmirc #asco23
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter